Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 9 (September)

1. Screening for colorectal cancer in average-risk populations.
   Am J Med, 119(9): 728-35. [Abstract] [Full-text]
2. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
   Hum Mutat, 27(10): 1064. [Abstract] [Full-text]
3. The association between aspirin use and the incidence of colorectal cancer in women.
   Am J Epidemiol, 164(6): 567-75. [Abstract] [Full-text]
4. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
   Cancer Chemother Pharmacol, 58(6): 759-64. [Abstract] [Full-text]
5. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
   Cancer Chemother Pharmacol, 58(6): 794-801. [Abstract] [Full-text]
6. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis.
   Int J Cancer, 119(9): 2127-35. [Abstract] [Full-text]
7. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland.
   Int J Cancer, 119(9): 2155-64. [Abstract] [Full-text]
8. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas.
   Int J Cancer, 119(9): 2098-104. [Abstract] [Full-text]
9. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis.
   Oncogene, 25(40): 5527-36. [Abstract] [Full-text]
10. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.
    J Clin Oncol, 24(26): 4285-92. [Abstract] [Full-text]
11. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    J Clin Oncol, 24(26): 4301-8. [Abstract] [Full-text]
12. Calcitriol sensitizes colon cancer cells to H2O2-induced cytotoxicity while inhibiting caspase activation.
    J Steroid Biochem Mol Biol, 101(2): 151-60. [Abstract] [Full-text]
13. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.
    Int J Radiat Oncol Biol Phys, 66(2): 505-13. [Abstract] [Full-text]
14. Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.
    Int J Radiat Oncol Biol Phys, 66(2): 500-4. [Abstract] [Full-text]
15. Chemotherapy with preoperative radiotherapy in rectal cancer.
    N Engl J Med, 355(11): 1114-23. [Abstract] [Full-text]
16. High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation.
    Oncogene, 25(41): 5693-706. [Abstract] [Full-text]
17. Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer.
    J Invest Dermatol, 126(10): 2158-9. [Abstract] [Full-text]
18. Pharmacogenomics of colorectal cancer prevention and treatment.
    Cancer Invest, 24(6): 630-9. [Abstract] [Full-text]
19. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    J Invest Dermatol, 126(10): 2302-7. [Abstract] [Full-text]
20. Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors.
    Biochem Pharmacol, 72(8): 981-91. [Abstract] [Full-text]
21. Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) mice.
    Mol Carcinog, 45(10): 764-73. [Abstract] [Full-text]
22. Robotic-assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancer.
    Surg Endosc, 20(10): 1521-5. [Abstract] [Full-text]
23. Flavonoid intake and colorectal cancer risk in men and women.
    Am J Epidemiol, 164(7): 644-51. [Abstract] [Full-text]
24. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers.
    Am J Epidemiol, 164(7): 652-64. [Abstract] [Full-text]
25. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature.
    Blood, 108(7): 2339-48. [Abstract] [Full-text]
26. Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens.
    Radiology, 241(1): 132-41. [Abstract] [Full-text]
27. Detection of colorectal polyps: comparison of multi-detector row CT and MR colonography in a colon phantom.
    Radiology, 241(1): 125-31. [Abstract] [Full-text]
28. Role of conventional treatments on circulating and monocyte-derived dendritic cells in colorectal cancer.
    Clin Immunol, 121(1): 74-80. [Abstract] [Full-text]
29. Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens.
    Am J Kidney Dis, 48(4): 580-6. [Abstract] [Full-text]
30. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
    Hum Pathol, 37(10): 1259-67. [Abstract] [Full-text]
31. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
    JAMA, 296(12): 1507-17. [Abstract] [Full-text]
32. Prediction of germline mutations and cancer risk in the Lynch syndrome.
    JAMA, 296(12): 1479-87. [Abstract] [Full-text]
33. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
    JAMA, 296(12): 1469-78. [Abstract] [Full-text]
34. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Br J Surg, 93(10): 1215-23. [Abstract] [Full-text]
35. Current role of radiofrequency ablation for the treatment of colorectal liver metastases.
    Br J Surg, 93(10): 1192-201. [Abstract] [Full-text]
36. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis.
    Br J Surg, 93(10): 1258-64. [Abstract] [Full-text]
37. Reactive lymphoid hyperplasia of the liver in a patient with colon cancer: report of two cases.
    BMC Gastroenterol, 6: 25. [Abstract] [Full-text]
38. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Science, 313(5795): 1960-4. [Abstract] [Full-text]
39. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
    J Clin Oncol, 24(28): 4620-5. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.